Epidemiology

Every day up to twelve people come to the NAKO health study’s Berlin-North Study Center to be examined from head to toe. Now, Tobias Pischon and his team at the Max Delbrück Center have welcomed their 5,555th participant. The researcher explains why the data they collect are so important.

A team led by Dr. Lina Jaeschke and Professor Tobias Pischon of the MDC has investigated the individual factors associated with high and low levels of physical activity. The results, which have been published in the journal Scientific Reports, contain some surprises.

The dangerous life of the couch potato: People who spend too long sitting are at higher risk of obesity, diabetes, and heart disease. In the citizen science project SMOVE, the MDC is joining forces with schoolchildren to research the relationship between environmental influences and sedentary behavior.

The MRI study center at the Max Delbrück Center has already examined 5,000 participants as part of the nationwide German National Cohort (GNC). We talked to Professor Thoralf Niendorf, head of the MRI center, about what’s happening with the data – and Annett Anacker, the 5,000th participant in Berlin, tells us why she’s taking part.

Another milestone has been reached: In November 2018, the Max Delbrück Center for Molecular Medicine (MDC) welcomed the 5,000th participant at the MRI center of the German National Cohort (GNC) health study.

The Max Delbrück Center for Molecular Medicine (MDC) has been participating in the German National Cohort since 2014. More than 8,000 people have already been examined as part of this nationwide study into health and disease.

The German National Cohort’s MRI center at the MDC welcomes its 4,000th participant

We have reached the half-way mark. Ute Radeklau from Berlin is the 3,000th person to be examined in the Berlin Ultrahigh Field Facility at the Max Delbrück Center for Molecular Medicine in the context of the largest German health study NAKO.

The Berlin-Nord Study Centre has now recruited half of the 10,000 volunteers for Germany’s largest ever cohort study. Across Germany, a total of 200,000 people will participate in the study, who will be carefully examined and thereafter observed for twenty to thirty years. The large-scale study will serve the improvement of prevention, early detection and treatment of widespread diseases.